Current filters:  
United States
Life Sciences, Biotechnology & Nanotechnology
United States
Duane Morris LLP
With each passing year, the long-predicted aspirational advantages of 3D printing in the life sciences industry become a reality.
Arnold & Porter
The numerous requirements to legally market a medical device, drug, biologic, or combination thereof in the United States are meant to reassure consumers that these medical products are safe and that the scope of their effectiveness is understood.
L2 Counsel
Increased funding plus employees that need an office makes the Life Sciences real estate sector resilient in a global pandemic
FTI Consulting
Internet-connected healthcare devices, ubiquitous in hospitals, are often rife with vulnerabilities. Here's how hospitals can keep their networks secure and patients safe.
Hughes Hubbard & Reed LLP
This week FinCEN issued an advisory regarding COVID-19-related unemployment insurance fraud, and legislation was introduced in the House of Representatives that would expand corporate tax incentives to invest in ...
The October Mintz Life Sciences Newsletter brings the latest developments in life sciences, legal insights, and industry activity straight to your inbox.
Fenwick & West LLP
This survey is a special interim report to highlight changes in the Silicon Valley venture capital environment through August 2020 in light of the COVID-19 pandemic.
You'd be forgiven in the current climate of coronavirus and election season, to name just a couple hot issues of the day, for missing two recent announcements from the FDA about its digital health program.
Reed Smith
The Pelvic Mesh MDLs are now all but over, with all but a few stragglers either settled or remanded. But the specious logic used in that litigation to overturn decades of precedent that had...
Reed Smith
There was an awful lot for defense counsel to contend with in Cavanaugh v. Stryker Corp., 2020 WL 5937405 (Fl. Dist. Ct. App., 4th Dist. Oct. 7, 2020).
Morrison & Foerster LLP
In this first of a four-part podcast series on the science, regulatory framework, commercial transactions, and privacy and data security ...
The Centers for Medicare and Medicaid Services recently issued a proposed rule that would grant Medicare coverage to breakthrough medical devices immediately upon FDA approval.
Oblon, McClelland, Maier & Neustadt, L.L.P
In two decisions this year district courts have addressed the "safe harbor" provision of 35 U.S.C. § 271(e)(1) in motions to dismiss a patent infringement count.
Reed Smith
Every now and then something happens that's unique. It's hardly unique for defense counsel to send us a case, with his/her client's consent and invite us
Reed Smith
Plaintiffs often prefer to be in state court, and when we first started doing a lot of product liability litigation way back when, we were struck by how much time ...
Arnold & Porter
The evolution of medical technology has led to extraordinary advances that benefit patients experiencing a broad range of health problems, and the role of clinicians has been crucial to...
Reed Smith
A great woman once said "When they go low, we go high." Apropos of nothing in particular these days, we have been thinking about the issue of tone recently.
Duane Morris LLP
On September 23, 2020, the U.S. Food and Drug Administration (FDA) published a proposed rule amending the agency's regulations concerning "intended uses."
Cooley LLP
Cooley advised Manchester Financial Group on its sale of five blocks of Manchester Pacific Gateway, a future waterfront development site in downtown San Diego, to premier life sciences...
Sheppard Mullin Richter & Hampton
On September 23, the U.S. Food and Drug Administration (FDA) published a proposed rule to modify its intended use regulations.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Popular Authors
Font Size:
Mondaq Social Media